Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report

Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report

Hepatoid adenocarcinoma of the lung (HAL) is a rare extrahepatic tumor characterized by histologic features of hepatocellular carcinoma. The standard treatment for nonresectable HAL has not been established, though traditionally, these tumors have been treated with platinum-based chemotherapy. Here,...

Full description

Bibliographic Details
Main Authors: Galina G. Lagos, MD, Jarett L. Feldman, MD, Anjali Saqi, MD, MBA, Catherine A. Shu, MD
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:JTO Clinical and Research Reports
Subjects:
Hepatoid adenocarcinoma
Chemoimmunotherapy
Tumor mutation burden
Case report
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364320301818

Internet

http://www.sciencedirect.com/science/article/pii/S2666364320301818

Similar Items